Related Experiment Video
Updated: Aug 28, 2025

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
SERPINB8 and furin regulate ITGAX expression and affect the proliferation and invasion of melanoma cells
Li Ni1, Pin Li2, Mingming Li1
1Department of Dermatology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Abstract:
In the past 10 years, the systemic treatment of advanced melanoma has undergone tremendous changes through the development of targeted therapy. However, there is still a long way to go. This study aims to characterize the function and interaction of ITGAX, SERPINB8 and furin in BRAF V600E mutant melanoma. Differentially expressed genes related to BRAF V600E mutation and BRAFi treatment were obtained by analysing GSE141484 and GSE22838. two kinds of BRAFi (Vemurafenib, 10 μM; Dabrafenib, 1 μM) were used to treat A375 and 1205Lu cells, respectively. The expression of ITGAX, SERPINB8 and Furin in A375 and 1205Lu cells was down-regulated by specific siRNAs, and cell proliferation, clone formation and invasion were detected by CCK-8, colony formation and transwell assays. The physical binding of furin and SERPINB8 was detected by immunoprecipitation. BRAFi treatment down-regulated the ITGAX and SERPINB8 expression and did not change furin expression. Knockdown of ITGAX and SERPINB8 both inhibited the proliferation and invasion of A375 and 1205Lu cells. Knocking down SERPINB8 down-regulated the expression of ITGAX. Furin knockdown and inhibitors all up-regulated the protein level of ITGAX. SERPINB8 can physically bind to furin. In summary, SERPINB8 and furin regulate the expression of ITGAX in melanoma cells, and ITGAX significantly promotes the proliferation and invasion of melanoma cells.
Insights
Investigating ITGAX, SERPINB8, and furin in BRAF V600E mutant melanoma reveals that SERPINB8 and furin regulate ITGAX, a protein promoting melanoma cell proliferation and invasion.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Targeted therapy has revolutionized advanced melanoma treatment, yet challenges remain.
- Understanding molecular mechanisms driving BRAF V600E mutant melanoma is crucial for therapeutic advancements.
Purpose of the Study:
- To elucidate the roles and interactions of ITGAX, SERPINB8, and furin in BRAF V600E mutant melanoma.
- To investigate how these factors influence melanoma cell behavior under BRAF inhibitor (BRAFi) treatment.
Main Methods:
- Analysis of gene expression datasets (GSE141484, GSE22838) related to BRAF V600E mutation and BRAFi treatment.
- In vitro experiments using A375 and 1205Lu melanoma cells treated with BRAF inhibitors (Vemurafenib, Dabrafenib).
- Gene knockdown using siRNAs, cell proliferation assays (CCK-8), colony formation assays, invasion assays (Transwell), and immunoprecipitation.
Main Results:
- BRAFi treatment downregulated ITGAX and SERPINB8 expression but did not affect furin levels.
- Knockdown of ITGAX or SERPINB8 inhibited melanoma cell proliferation and invasion.
- SERPINB8 knockdown decreased ITGAX expression, while furin inhibition or knockdown increased ITGAX protein levels.
- SERPINB8 physically binds to furin.
Conclusions:
- SERPINB8 and furin collaboratively regulate ITGAX expression in melanoma cells.
- ITGAX significantly drives melanoma cell proliferation and invasion.
- These findings offer insights into novel therapeutic targets for advanced melanoma.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
GTPases and their Regulation
Large G-proteins,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

